Skip to content

Built by people who have seen RBQM go wrong in the real world

Bringing a culture of risk to clinical research.

The Qlarix story

We saw the gap. So we built the system we wanted clinical teams to have.

We founded Qlarix after seeing the same challenge again and again: clinical teams were expected to implement RBQM, yet many were still relying on disconnected spreadsheets, documents and systems that made oversight harder than it needed to be.

The alternatives were often too complex, too expensive or focused on only one part of the process. We knew there had to be a better way.

That is why we created WiseCLIN: to help teams reduce manual effort, eliminate duplicated work, identify and address risks earlier, strengthen compliance and lower the cost of managing RBQM across studies.

Explore WiseCLIN

What guides us

The principles that guide every Qlarix partnership and shape every aspect of WiseCLIN.

  • Risk-based thinking
  • Integrity
  • Collaboration
  • Quality
  • Innovation
  • Efficiency
  • Compliance
  • Transparency
  • Expertise

Meet the team

Research expertise and technology leadership, working side by side to make clinical oversight smarter.

Leire Zúñiga

Leire Zúñiga

CQO/CSO & Co-Founder

PharmD, PhD · RBQM Leader

John Michaloudis

John Michaloudis

CEO & Co-Founder

B.Comm · Microsoft MVP

Where you'll find us

Headquartered in Spain with teams across four continents — we partner with sponsors and CROs around the world.

Qlarix headquarters in Spain

Spain

Our headquarters — where Qlarix and WiseCLIN are built.

See WiseCLIN in Action

Complete the form to book a personalised demo and see how WiseCLIN turns fragmented RBQM activities into one connected, traceable oversight workflow.

  • Identify and address emerging risks earlier
  • Reduce manual effort and duplicated work
  • Strengthen ICH E6(R3) alignment and inspection readiness
  • Gain clearer oversight across studies, teams and portfolios